| Literature DB >> 27416029 |
Claudine Kocher1,2, Amy C Morrison2, Mariana Leguia2, Steev Loyola2, Roger M Castillo2, Hugo A Galvez3, Helvio Astete2, Carmen Flores-Mendoza2, Julia S Ampuero2, Daniel G Bausch2, Eric S Halsey2, Manuel Cespedes4, Karine Zevallos5, Ju Jiang6, Allen L Richards6.
Abstract
Using a large, passive, clinic-based surveillance program in Iquitos, Peru, we characterized the prevalence of rickettsial infections among undifferentiated febrile cases and obtained evidence of pathogen transmission in potential domestic reservoir contacts and their ectoparasites. Blood specimens from humans and animals were assayed for spotted fever group rickettsiae (SFGR) and typhus group rickettsiae (TGR) by ELISA and/or PCR; ectoparasites were screened by PCR. Logistic regression was used to determine associations between patient history, demographic characteristics of participants and symptoms, clinical findings and outcome of rickettsial infection. Of the 2,054 enrolled participants, almost 2% showed evidence of seroconversion or a 4-fold rise in antibody titers specific for rickettsiae between acute and convalescent blood samples. Of 190 fleas (Ctenocephalides felis) and 60 ticks (Rhipicephalus sanguineus) tested, 185 (97.4%) and 3 (5%), respectively, were positive for Rickettsia spp. Candidatus Rickettsia asemboensis was identified in 100% and 33% of the fleas and ticks tested, respectively. Collectively, our serologic data indicates that human pathogenic SFGR are present in the Peruvian Amazon and pose a significant risk of infection to individuals exposed to wild, domestic and peri-domestic animals and their ectoparasites.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27416029 PMCID: PMC4944934 DOI: 10.1371/journal.pntd.0004843
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Univariate logistic regression analysis of age, occupation and other risk factors for active spotted fever group (SFGR) infection compared to infections due to other causes.
| Variable | SFG seroconversion (n = 38) | Other febrile illnesses (n = 2016) | OR (95% CI) | |||
|---|---|---|---|---|---|---|
| No | % | No | % | |||
| Age median (range) | 25 (21–33) | 23(17–36) | 1.009 | 0.42 | ||
| Age by categories | ||||||
| Age < = 20 | 8 | 798 | - | |||
| Age 21–35 | 22 | 683 | 3.2 (1.4–7.2) | 0.05 | ||
| Age >35 | 8 | 535 | 1.5 (0.6–4) | 0.427 | ||
| Male sex | 21 | 55.2 | 997 | 50.5 | 1.2 (0.63–2.30) | 0.56 |
| Occupation of total n = 2042 | ||||||
| Students | 4 of 38 | 10.5 | 646 of 2004 | 32 | 0.25 (0.08–0.69) | 0.008 |
| High-risk exposure occupations | 15 of 38 | 39.5 | 450 of 2004 | 21.1 | 2.25 (1.2–4.4) | 0.016 |
| Home-based occupations | 13 of 38 | 34.2 | 485 of 2004 | 24.2 | 1.62 (0.83–3.2) | 0.159 |
| Other occupations | 6 of 38 | 15.8 | 423 of 2004 | 21.1 | 0.7 (0.3–1.7) | 0.428 |
| Contact with febrile individual during the past 15 days | 19 of 38 | 50 | 824 of 2014 | 41 | 1.44 (0.76–2.7) | 0.26 |
| Animal contact reported | 29 | 76 | 1264 | 62.7 | 1.9 (0.9–4) | 0.09 |
| Trip outside of city during 15 days prior to presentation | 6 | 15.8 | 209 | 10.4 | 1.62 (0.67–3.9) | 0.284 |
Univariate logistic regression analysis of symptoms and clinical findings during infection with SFGR compared to other febrile illnesses.
| Variable | SFGR seroconverters n = 38 | Other febrile illnesses n = 2016 | OR 95% CI | |||
|---|---|---|---|---|---|---|
| No | % | No | % | |||
| Chills | 38 | 100 | 1928 | 95.6 | - | - |
| Headache | 38 | 100 | 1999 | 98.1 | - | - |
| Malaise | 37 | 97.3 | 2004 | 99.4 | 0.22 (0.02–1.7) | 0.153 |
| Myalgia | 35 | 92 | 1865 | 93 | 0.94 (0.3–3.1) | 0.925 |
| Generalized body pain | 34 | 89.4 | 1876 | 93 | 0.63 (0.22–1.8) | 0.39 |
| Joint pain | 33 | 87 | 1839 | 91.2 | 0.64 (0.2–1.6) | 0.35 |
| Retrooccular pain | 33 | 87 | 1699 | 84 | 1.23 (0.5–3.1) | 0.67 |
| Anorexia | 33 | 86.8 | 1854 | 91.7 | 0.58 (0.2–1.5) | 0.26 |
| Nausea | 29 | 76.3 | 1540 | 76.4 | 0.99 (0.5–2.1) | 0.99 |
| Dizziness | 28 | 73.7 | 1552 | 77 | 0.83 (0.4–1.7) | 0.63 |
| Abdominal pain | 25 | 65.8 | 1358 | 67.3 | 0.93 (0.5–1.8) | 0.84 |
| Photophobia | 22 | 58 | 777 | 38.5 | 2.19 (1.1–4.2) | 0.018 |
| Vomiting | 18 | 47.3 | 876 | 43.4 | 1.17 (0.6–2.2) | 0.63 |
| Conjunctival injection | 17 | 44.7 | 744 | 37 | 1.38 (0.7–2.6) | 0.32 |
| Rash | 16 | 42.1 | 1036 | 51.4 | 0.69 (0.4–1.3) | 0.26 |
| Diarrhea | 12 | 31.6 | 756 | 37.5 | 0.77 (0.4–1.5) | 0.46 |
| Itching | 12 | 31.6 | 794 | 39.4 | 0.71 (0.4–1.4) | 0.33 |
| Otalgia | 8 | 21 | 266 | 13 | 1.75 (0.8–3.9) | 0.16 |
| Cough | 7 | 18.4 | 366 | 18.1 | 1.01 (0.4–2.3) | 0.97 |
| Rhinorrhea | 5 | 13.2 | 319 | 15.8 | 0.8 (0.3–2) | 0.66 |
| Sore throat | 5 | 13.1 | 392 | 19.4 | 0.63 (0.2–1.6) | 0.34 |
| Expectoration | 4 | 10.5 | 259 | 12.9 | 0.8 (0.3–2.3) | 0.67 |
| Dyspnea | 4 | 10.5 | 170 | 8.9 | 1.2 (0.4–0.01) | 0.72 |
| Any bleeding manifestations | 1 | 2.6 | 234 | 11.6 | 0.2 (0.02–1.5) | 0.12 |
| Temperature, mean (SD) of total n = 2048 | 38.1 (0.89) | 37.9 (0.86) | 1.2 (0.9–1.8) | 0.245 | ||
| Tourniquet positive | 15 of 38 | 39.5 | 651 of 1972 | 33 | 1.32 (0.7–2.6) | 0.40 |
Univariate analysis of the outcome of infection due to SFGR compared to other febrile illnesses.
| Variable | SFGR seroconverters, n = 38 | Other febrile illnesses, n = 2016 | OR 95% CI | |||
|---|---|---|---|---|---|---|
| No | % | No | % | |||
| Hospitalization | 8 | 21 | 556 | 27.6 | 0.70 (0.3–1.5) | 0.37 |
| Mean duration of fever (SD, range in d) | 4.3 (2.6, 1–14) | 4.1 (1.9, 1–17) | 1.04 (0.9–1.2) | 0.62 | ||
| Mean duration of illness (SD, range in d) | 9.34 (6.1, 2–26) | 7.4 (4, 1–30) | 1.09 (1–1.2) | 0.004 | ||
| Mean duration of Hospitalization (SD, range in d) | 4.1 (3.1, 1–8) | 5.2 (2.9, 1–31) | 0.82 (0.6–1.2) | 0.258 | ||
| Persistence of symptoms at follow-up visit | 8 | 21 | 214 | 10 | 2.24 (1–4.9) | 0.046 |
Adjusted Odds-ratios based on multivariate logistic regression model of spotted fever group seroconverters (n = 38) compared to other febrile illnesses (n = 2016).
| Variable | OR (95% CI) | |
|---|---|---|
| High-risk exposure occupation | 3.7 (1.6–8.5) | 0.001 |
| Home-based occupation | 2.4 (1–5.6) | 0.042 |
| Duration of illness | 1.1 (1–1.1) | 0.005 |
Overview of ectoparasites collected.
| Total | 190 | 4 | 30 | 60 |
| Collected from dogs | 161 | - | 5 | 60 |
| Collected from cats | 29 | - | - | - |
| Collected from poultry | - | 4 | 25 | - |
| Positive by qPCR and/or nested PCR (17-kD), n (%) | 185 (97.4%) | 0 (0%) | 0 (0%) | 3 (5%) |
| Positive for | 185 of 185 tested | 3 of 3 tested | ||
| Positive for | 76 of 76 tested | 1 of 3 tested |